Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.29307 | 11 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.27685 | 11 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.27885 | 11 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.23643 | 11 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.22685 | 11 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.32968 | 11 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.29367 | 11 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.26066 | 11 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.24124 | 11 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.26816 | 11 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.26279 | 11 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.25055 | 11 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.26348 | 11 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.26791 | 11 |